The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

Clinical trial NCT05964543 · UNKNOWN

Trial details

NCT number: NCT05964543
Sponsor: QureBio Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Junction (GEJ) Adenocarcinoma

Start date: 2023-06-21
Primary completion: 2024-08-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.